These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36875290)

  • 1. Comparative Effectiveness Research using Bayesian Adaptive Designs for Rare Diseases: Response Adaptive Randomization Reusing Participants.
    Tang F; Gajewski BJ
    Stat Biopharm Res; 2023; 15(1):154-163. PubMed ID: 36875290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using Adaptive Designs to Avoid Selecting the Wrong Arms in Multiarm Comparative Effectiveness Trials.
    Gajewski BJ; Statland J; Barohn R
    Stat Biopharm Res; 2019; 11(4):375-386. PubMed ID: 31839873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomization.
    Brown AR; Gajewski BJ; Aaronson LS; Mudaranthakam DP; Hunt SL; Berry SM; Quintana M; Pasnoor M; Dimachkie MM; Jawdat O; Herbelin L; Barohn RJ
    Trials; 2016 Aug; 17(1):428. PubMed ID: 27577191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conducting a bayesian multi-armed trial with response adaptive randomization for comparative effectiveness of medications for CSPN.
    Brown AR; Gajewski BJ; Mudaranthakam DP; Pasnoor M; Dimachkie MM; Jawdat O; Herbelin L; Mayo MS; Barohn RJ
    Contemp Clin Trials Commun; 2023 Dec; 36():101220. PubMed ID: 37965484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doubly adaptive biased coin design to improve Bayesian clinical trials with time-to-event endpoints.
    Cao W; Zhu H; Wang L; Zhang L; Yu J
    Stat Med; 2024 Apr; 43(9):1743-1758. PubMed ID: 38387866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of statistical features of a Bayesian two-armed responsive adaptive randomization trial with post hoc analysis of time trend drift.
    Shergina E; Richter KP; Zhang C; Mussulman L; Nazir N; Gajewski BJ
    J Biopharm Stat; 2024 Jun; ():1-15. PubMed ID: 38847351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Bayesian sequential design with adaptive randomization for 2-sided hypothesis test.
    Yu Q; Zhu L; Zhu H
    Pharm Stat; 2017 Nov; 16(6):451-465. PubMed ID: 28980435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian adaptive randomization designs for targeted agent development.
    Lee JJ; Xuemin Gu ; Suyu Liu
    Clin Trials; 2010 Oct; 7(5):584-96. PubMed ID: 20571130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Building efficient comparative effectiveness trials through adaptive designs, utility functions, and accrual rate optimization: finding the sweet spot.
    Gajewski BJ; Berry SM; Quintana M; Pasnoor M; Dimachkie M; Herbelin L; Barohn R
    Stat Med; 2015 Mar; 34(7):1134-49. PubMed ID: 25640114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian dose selection design for a binary outcome using restricted response adaptive randomization.
    Meinzer C; Martin R; Suarez JI
    Trials; 2017 Sep; 18(1):420. PubMed ID: 28886745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DHA supplementation for early preterm birth prevention: An application of Bayesian finite mixture models to adaptive clinical trial design optimization.
    Shi X; Wick JA; Christifano DN; Carlson SE; Brown AR; Mudaranthakam DP; Gajewski BJ
    Contemp Clin Trials; 2024 Jul; 144():107633. PubMed ID: 39013543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian adaptive randomization in a clinical trial to identify new regimens for MDR-TB: the endTB trial.
    Cellamare M; Milstein M; Ventz S; Baudin E; Trippa L; Mitnick CD
    Int J Tuberc Lung Dis; 2016 Dec; 20(12):8-12. PubMed ID: 28240566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing a Bayesian hierarchical adaptive platform trial design for stroke patients.
    Gao G; Gajewski BJ; Wick J; Beall J; Saver JL; Meinzer C;
    Trials; 2022 Sep; 23(1):754. PubMed ID: 36068547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of multi-arm multi-stage design and adaptive randomization in platform clinical trials.
    Lin J; Bunn V
    Contemp Clin Trials; 2017 Mar; 54():48-59. PubMed ID: 28089763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayesian Adaptive Randomization and Trial Monitoring with Predictive Probability for Time-to-event Endpoint.
    Yin G; Chen N; Lee JJ
    Stat Biosci; 2018 Aug; 10(2):420-438. PubMed ID: 30559900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian response adaptive randomization using longitudinal outcomes.
    Hatayama T; Morita S; Sakamaki K
    Pharm Stat; 2015; 14(5):369-76. PubMed ID: 26099995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bayesian adaptive trials offer advantages in comparative effectiveness trials: an example in status epilepticus.
    Connor JT; Elm JJ; Broglio KR;
    J Clin Epidemiol; 2013 Aug; 66(8 Suppl):S130-7. PubMed ID: 23849147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.